Future of Aging

The companies, labs, and builders trying to turn AI-powered longevity research into real-world tools, therapies, and platforms.

The future of aging is being shaped not only by papers and lab discoveries, but also by organizations willing to build around them. This database tracks the companies, labs, and backers moving through biological age research, AI-driven discovery, prevention, and healthspan infrastructure.

Altos Labs

Cellular rejuvenation and reprogramming using partial reprogramming factors

Private biotech

Calico

Aging biology and longevity research

Alphabet-backed research company

Retro Biosciences

Cellular drivers of aging and healthy lifespan extension

Private biotech

Unity Biotechnology

Senolytic therapies to clear senescent cells

Public biotech

BioAge Labs

AI-driven identification of longevity drug targets

Private biotech

Related Articles

What Is AI-Powered Longevity? How AI Is Changing Drug Discovery
AI + Longevity Research Watch Healthspan
Research publication: Evidence levels are noted per entry. This content is for educational purposes and does not constitute medical advice. Data reflects current research status and is updated as the field evolves.